Although options are considered short-term instruments, it's also possible to use them as part of a longer-term strategy. Read More

Sure, marijuana stocks are temporarily down. But recent trends indicate a sharp acceleration in pot-friendly laws. Read More

The trade war remains mired in stalemate but corporate managers are adjusting. That’s good news for stocks. Read More

As stocks hit new highs and risks of a correction get greater, here's how to protect your wealth. Read More

This record-setting rally shows plenty of animal spirits, but it wouldn’t take much for investors to hit the ground. Read More

We don't recommend buying stock in Teva Pharmaceutical, but there's a way to profit from Teva even if its share price doesn’t move. Read More

We’re seeing euphoria based on greed, not fundamentals. You need to rebalance your portfolio. Read More

Marijuana companies are having trouble raising capital. Here’s what you need to know, to pick the ultimate survivors of pot's financial crisis. Read More

During the holiday season in Q4 2018, the stock market tanked and finished the year lower. Conditions are lining up for a repeat. Read More

Due to an accounting blunder, NV5 misstated earnings guidance for next year and its stock tanked. Here's how our expert plans to cash in. Read More